Table 1.
Laboratory test results on admission.
| Blood test | |||
| WBC | 5100/mm3 | CH50 | 21 U/mL |
| Neutro | 45.5% | C3 | 81 mg/dL |
| Lymph | 45.5% | C4 | 8 mg/dL |
| Mono | 6.0% | IgG | 1525 mg/dL |
| Eo | 0% | IgA | 190 mg/dL |
| Baso | 0% | IgM | 40 mg/dL |
| RBC | 219/mm3 | ANA | ×320 |
| Reticuro | 7.2% | Speckled | ×320 |
| Hb | 6.4 g/dL | Anti-DNA antibody (RIA) | 27 IU/mL |
| Hct | 18.0% | Anti-SS-A antibody | 1160 U/mL |
| Plt | 0.4/mm3 | Anti-SS-B antibody | (−) |
| PT-INR | 1.11 | Anti-Topo-1 antibody | (−) |
| ATPP | 29.1 sec (contro; 30.3 sec) | Anti-RNP antibody | 184 U/mL |
| FDP | 17.4 μg/dL | Anti-Sm antibody | (−) |
| D-D | 8.78 μg/dL | MPO-ANCA | (−) |
| ESR | 66 mm/h | Anti cardiolipin antibody (IgG) | 13 U/mL |
| TP | 6.9 g/dL | Anti-CLβ2GP1 antibody | (−) |
| ALB | 3.7 g/dL | LAC | (−) |
| BUN | 10 mg/dL | Anti platlet antibody | (−) |
| Cr | 0.54 mg/dL | PA-IgG | 2150 ng/107 cell |
| UA | 3.0 mg/dL | IC-C1q | 3.3 μg/mL |
| Na | 136 mmol/L | Direct Coombs test | (−) |
| K | 3.9 mmol/L | Indirect Coobms test | (−) |
| CL | 102 mmol/L | CMV IgG | (+) |
| T-Bil | 2.9 mg/dL | CMV IgM | (−) |
| D-Bil | 0.9 mg/dL | CMV Ag | (−) |
| AST | 61 IU/L | EBV EBNA | (−) |
| ALT | 35 IU/L | EBV-VCAIgG | (+) |
| LDH | 915 IU/L | EBV Ag | (+) |
| CK | 77 IU/L | EBV-VCAIgM | (−) |
| CRP | <0.3 mg/dL | HBs Ag | (−) |
| Urianalysis | |||
| Glu | (−) | ||
| Protein | (−) | ||
| RBC | (−) | ||
| WBC | (−) | ||
| abnormal cyst | (−) | ||